Skip to main content

Table 1 Patient demographic and clinical characteristics at baseline according to gender (Phase 1)

From: Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment — a comparative study

Mean ± SD

Women(173)

Men(90)

Overall(263)

Age (years)

83.1 ± 7.2

82.6 ± 6.9

82.9 ± 7.1

Weight (kg)

62.9 ± 11.6

73.9 ± 10.1

69.8 ± 12.2

Height (m)

1.5 ± 0.1

1.6 ± 0.1

1.6 ± 0.1

BMI (Kg/m2)

26.4 ± 4.1

27.0 ± 3.2

26.6 ± 3.9

SBP (mm Hg)

130.6 ± 17.5

130.9 ± 17.7

130.7 ± 17.5

DBP (mm Hg)

70.8 ± 11.1

71.7 ± 11.3

71.1 ± 11.2

Creatinine (mg/dl)

1.1 ± 0.9

1.30 ± 0.4

1.2 ± 0.8

Body surface (m2)

1.6 ± 0.2

1.8 ± 0.1

1.7 ± 0.2

GFR (ml/min/1.73 m2)

61.0 ± 16.9

59.2 ± 16.1

60.4 ± 16.7

CrCl (ml/min)

43.0 ± 11.7

47.5 ± 12.9

45.2 ± 12.2

CrCl-BS (ml/min/1.73 m2)

46.7 ± 11.6

44.5 ± 10.9

45.0 ± 11.4

Total number drugs patient

7.3 ± 3.0

7.2 ± 2.9

7.3 ± 2.9

Drugs with restrictions per patient

4.0 ± 1.9

4.0 ± 2.9

4.0 ± 2.0

Number of DRP per patient

0.7 ± 1.1

0.6 ± 1.1

0.7 ± 1.1

Prevalence of DI (%)

18.3 ± 28.9

15.8 ± 28.4

17.5 ± 28.2

Population with DRP %(n)

35.6(32)

38.2(66)

37.3(98)

Comorbidity %(n)

   

 Hypertension

71.7%(124)

67.8%(61)

70.3%(185)

 T2DM

19.7%(34)

24.4%(22)

21.3%(56)

 Dyslipidemia

37.0%(64)

36.7%(33)

36.9%(97)

 Hyper/Hypo Thy

8.1(14)

1.1%(1)

5.7%(15)

 CVD

26.6(46)

31.1%(28)

28.1%(74)

  1. Abbreviations: BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, T2DM Type 2 Diabetes Mellitus, CVD Cardiovascular Disease, THY Thyroidsm, GFR Rate of Glomerular filtration, CrCl Creatinine Clearance, CrCl-BS Creatinine Clearance adjusted to body surface, RI renal impairment, DRP Drug-related problem, DI Dosing inadequacy, Drugs with restrictions (dose adjustment needed in case of renal impairment (RI)) per patient [2022], SD Standard deviation.